TWO NEW DRUGS IN EPILEPSY THERAPY
Abstract
Two new drugs increase the range and the effectiveness of the control of epileptic seizures.
Trimethyloxazolidine dione (tridione) used alone has proved wonderfully effective in controlling seizures of the petit mal triad; petit mal (pykno-epilepsy), myoclonic jerks and akinetic seizures. In contrast, grand mal convulsions were not helped or were made worse. Psychomotor seizures were occasionally aided by tridione combined with an anticonvulsant drug.
Methyl phenyl ethyl hydantoin (mesantoin) used in 35 patients, did not help petit mal, but in approximately one-third of patients subject to frequent major seizures it has replaced diphenyl hydantoin (dilantin) with profit, the benefit resulted either from a reduction in the frequency of convulsions or from an absence of the unpleasant side effects of either muscular incoordination or gum hypertrophy. Generalized rash or somnolence were side effects which limited the usefulness of the drug in many patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
